2-(β-D-Glucopyranosyl)-5-methyl-1,3,4-oxadiazole

2-(β-D-Glucopyranosyl)-5-methyl-1,3,4-oxadiazole is a C-glycoside compound studied as an enzyme inhibitor for potential use in diabetes treatment. == Chemistry == 2-(β-D-Glucopyranosyl)-5-methyl-1,3,4-oxadiazole combines a glucose molecule linked to an oxadiazole. It is classified as a C-glycoside because the sugar is attached by a stable carbon-to-carbon bond. == Mechanism of action == The compound 2-(β-D-Glucopyranosyl)-5-methyl-1,3,4-oxadiazole works by blocking an enzyme called glycogen phosphorylase, which breaks down stored sugar in the body. == Research == Researchers hope that by using 2-(β-D-Glucopyranosyl)-5-methyl-1,3,4-oxadiazole to block glycogen phosphorylase, they may be able to design future medications that control high blood sugar. == History == Despite being tested in laboratories and analyzed using protein crystallography to see how it binds to glycogen phosphorylase, it is a research compound rather than an approved medicine. == References ==